Sulfamethoxazole-Trimethoprim Dosing for an 11.98 kg Infant
For an infant weighing 11.98 kg, administer sulfamethoxazole 240 mg with trimethoprim 48 mg (equivalent to 1.5 standard tablets) orally every 12 hours for most common indications.
Dosing Calculation and Rationale
The standard pediatric dosing for sulfamethoxazole-trimethoprim is 40 mg/kg/day of sulfamethoxazole and 8 mg/kg/day of trimethoprim, divided into two doses every 12 hours 1, 2, 3. This is the FDA-approved dosing for urinary tract infections, acute otitis media, and shigellosis 3.
For this 11.98 kg infant:
- Total daily dose: 479.2 mg sulfamethoxazole + 95.84 mg trimethoprim
- Per dose (every 12 hours): 239.6 mg sulfamethoxazole + 47.92 mg trimethoprim
- Practical administration: 1.5 standard tablets (each containing 160 mg sulfamethoxazole/32 mg trimethoprim) = 240 mg/48 mg per dose
Indication-Specific Adjustments
For Urinary Tract Infections or Acute Otitis Media
Continue with the standard dosing above for 5-10 days depending on clinical response 2, 3.
For Pneumocystis Pneumonia Treatment
Higher dosing is required: 75-100 mg/kg/day sulfamethoxazole with 15-20 mg/kg/day trimethoprim, divided every 6 hours for 14-21 days 4, 3. For this 11.98 kg infant, this translates to approximately 1.5 tablets every 6 hours (upper limit dosing).
For Pneumocystis Prophylaxis
Lower dosing suffices: 150 mg/m² trimethoprim with 750 mg/m² sulfamethoxazole per day, divided twice daily, given 3 consecutive days per week 4, 5. This typically equates to 0.5-1 tablet twice daily on prophylaxis days for this weight range.
For Skin and Soft Tissue Infections (MRSA)
Use 8-12 mg/kg/day based on trimethoprim component in 2 divided doses 6. For this infant: 96-144 mg trimethoprim daily (approximately 1.5-2 tablets twice daily).
Critical Considerations
Age restriction: Sulfamethoxazole-trimethoprim is contraindicated in infants less than 2 months of age 3. Ensure this patient meets the minimum age requirement.
Recent pharmacokinetic data suggests WHO weight-band dosing may be suboptimal 7. The study demonstrated that children in the 10-15 kg range achieve lower drug exposure than adults with standard dosing. For optimal exposure matching adult levels, consider 25 mg/kg sulfamethoxazole with 5 mg/kg trimethoprim (approximately 300 mg/60 mg per dose for this infant) 7.
Monitoring requirements: Obtain complete blood count with differential and platelet count at initiation and monthly intervals to assess for hematologic toxicity, particularly neutropenia 5. This is especially important as leukopenia is the most common reason for drug discontinuation 8.
Renal function: If creatinine clearance is 15-30 mL/min, reduce dose by 50%; avoid use if <15 mL/min 3.
Common Pitfalls to Avoid
Do not use for neonates: The pharmacokinetics differ substantially in newborns, with half-lives of 16.5 hours for sulfamethoxazole and 19 hours for trimethoprim 9. Neonatal dosing requires specialized adjustment.
Avoid monotherapy for serious infections: Always ensure appropriate culture-guided therapy, as resistance patterns vary geographically 1.
Watch for hypersensitivity reactions: Rash occurs 2.5-fold more frequently with sulfamethoxazole-trimethoprim compared to other antibiotics 10. Discontinue immediately for Stevens-Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis 3.
Electrolyte monitoring: Recent data shows 10-fold increased risk of hyperkalemia and hyponatremia compared to other antibiotics 10. Monitor electrolytes in at-risk patients.